Search
Home | Research and Education | Funding Opportunities | ASTRO Radiation Oncology Resident Fellowship

ASTRO Radiation Oncology Resident Fellowship

The 2026 ASTRO Resident Fellowship program will provide a radiation oncology resident (PGY-3 or later) with funding for research and the professional development opportunity of a one-year assignment working part-time and remotely with colleagues at AstraZeneca. This program is supported by an educational grant from AstraZeneca.

Applications are due on Monday, June 29, 2026

Scientist with dropper

Overview

ASTRO offers this program to provide residents funding for research and to provide experiences working with industry. The flexible format of this program allows residents to meet the requirements of their residency programs while gaining additional professional skills.

The Fellow will lead a one-year research project at the Fellow's home institution with a local mentor. Research proposals will be analogous to those requested through the 2026 ASTRO Radiation Oncology Resident Fellowship with an emphasis on the intersection of radiation oncology and immuno-oncology in non-small cell lung cancer (NSCLC). A presentation on research progress will be made by the Fellow to AstraZeneca staff upon completion of the Fellowship.

The Fellow will commit at least one eight-hour day per week for one year to remote work with AstraZeneca, with flexibility to adjust their schedule as mutually agreed upon by the Fellow, the Fellow's residency program director, and AstraZeneca. The approximate work schedule will be negotiated before the Fellowship begins, and exceptions accommodated as needed without sacrificing residency training time. Funding will be available to reimburse limited travel to AstraZeneca sites.

The Fellow is encouraged to present their research findings at the ASTRO Annual Meeting and can be reimbursed for travel expenses to participate therein. The Fellow will receive a small honorarium and will not receive research support directly.

This program is supported by an educational grant from AstraZeneca.

  • Award Amount: Up to $50,000 plus $5,000 honorarium
  • Award Duration: One year
  • Deadline: Monday, June 29, 2026
  • Award Notification: July or August 2026
  • Start Date: No earlier than August 1, 2026

Eligibility

  • Applicant must hold a medical degree such as MD/PhD, MD, DO, or other equivalent degrees.
  • Applicant must be a senior resident (at least in PGY-3).
  • Applicant must be working in the field of radiation oncology, radiation or cancer biology, or radiation physics.
  • Applicant is required to commit at least 50% of their research efforts to the proposed project. The remainder of time may be devoted to clinical or other pursuits consistent with the objectives of the grant.
  • The Sponsoring Institution must be a public/state controlled or private institution of higher education or another qualified nonprofit organization in the U.S.

How to Apply

Applications must be submitted online through ProposalCentral by the deadline.

The proposal is composed of an application form that includes general audience and technical abstracts, an impact statement, research assurances, the signature of an institutional signing official and the signature of the residency program director. The following documents must also be uploaded:

  • Research Plan (six-page limit)
  • Biosketches of the applicant and lead mentor (five-page limit)
  • Budget and Budget Justification
  • Career Development Plan (one-page limit)
  • Letters of Support from the lead mentor and the residency program director. The research mentor may be the residency program director, and in this case only one letter of support is needed.
  • Letter of Institutional Support

251 18th Street South, 8th Floor
Arlington, VA 22202